{
    "response": "Imaging and CSF studies are required to confirm central demyelination and demonstrate dissemination in space and time, while excluding alternative inflammatory, infectious or structural causes. Electrophysiology and targeted blood tests help characterise the peripheral neuropathy and radiculopathy and identify reversible metabolic or autoimmune contributors before initiating disease-modifying therapy.\n\ninvestigations = [\"MRI of brain and entire spinal cord with gadolinium\", \"Lumbar puncture with CSF oligoclonal bands and IgG index\", \"CSF cell count and differential\", \"CSF protein and glucose\", \"Visual evoked potentials\", \"Optical coherence tomography of both optic nerves\", \"Automated perimetry (formal visual field testing)\", \"Nerve conduction studies and electromyography of lower limbs\", \"MRI of lumbar spine\", \"Full blood count\", \"Urea and electrolytes\", \"Liver function tests\", \"C-reactive protein\", \"Erythrocyte sedimentation rate\", \"Blood glucose\", \"HbA1c\", \"Vitamin B12 level\", \"Folate level\", \"Thyroid function tests\", \"Serum copper and ceruloplasmin\", \"Antinuclear antibody\", \"Extractable nuclear antigen panel\", \"Anti-double-stranded DNA antibody\", \"Antineutrophil cytoplasmic antibodies\", \"Serum angiotensin-converting enzyme level\", \"Aquaporin-4 (NMO) IgG antibody\", \"Myelin oligodendrocyte glycoprotein (MOG) IgG antibody\", \"Serum protein electrophoresis with immunofixation\", \"Serum HIV test\", \"Syphilis serology (e.g., RPR and TPPA)\"]"
}